Proteomics in Alzheimer's disease focuses on identifying and analyzing the complex network of proteins involved in its pathogenesis. This approach aims to uncover biomarkers for early diagnosis, track disease progression, and identify therapeutic targets. By analyzing protein profiles in brain tissues, cerebrospinal fluid, or blood samples, proteomics enables researchers to understand the molecular mechanisms underlying Alzheimer's disease and dementia.
Recent advancements in proteomic technologies such as mass spectrometry and protein microarrays have allowed for the discovery of novel protein biomarkers that reflect pathological changes in the brain, offering potential insights into disease mechanisms and personalized treatment strategies. Ultimately, proteomics holds promise in revolutionizing our understanding and management of Alzheimer's disease by providing valuable tools for early detection and targeted intervention.
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Make a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Health care professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Somali Red Crescent Society, Somalia
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States